MYOCARDIAL FUNCTION AND FFA METABOLISM IN HIV-METABOLIC SYNDROME

HIV 代谢综合征中的心肌功能和 FFA 代谢

• 批准号: 7603362
• 负责人: KEVIN E YARASHESKI
• 金额: $ 2.08万
• 依托单位: WASHINGTON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-04-01 至 2007-09-16
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7603362
• 关键词: Anti-Retroviral Agents; Appearance; Blood Circulation; Cardiac; Cardiovascular Diseases; Computer Retrieval of Information on Scientific Projects Database; Doppler Echocardiography; Dyslipidemias; Fatty Acids; Functional disorder; Funding; General Population; Grant; Heart; High Density Lipoprotein Cholesterol; Hypertriglyceridemia; Image; Institution; Insulin Resistance; Label; Left; Left Ventricular Dysfunction; Left ventricular structure; Link; Lipids; Liver; Mass Spectrum Analysis; Metabolic syndrome; Metabolism; Myocardial; Myocardium; Nonesterified Fatty Acids; Obesity; Palmitates; Pathogenesis; Positron-Emission Tomography; Radio; Rate; Reporting; Research; Research Personnel; Resources; Risk Factors; Skeletal Muscle; Source; Tissues; United States National Institutes of Health; Ventricular; Visceral; Woman; cardiovascular disorder risk; experience; men; oxidation; therapy design; uptake

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The risk for cardiovascular disease (CVD) and left ventricular dysfunction (LVD) is greater in HIV-infected people than in the general population, but the pathogenesis is unclear. Many HIV-infected people develop metabolic syndromes (HIV+MS) that include traditional CVD and LVD risk factors (dyslipidemia, insulin resistance, visceral adiposity) that are commonly observed in HIV-seronegative people and referred to as "The Metabolic Syndrome." We have reported that HIV+MS is characterized by an elevated free fatty acid rate of appearance (FFA Ra) in the circulation (i.e., increased whole-body lipolytic rate), and lipid accumulation in skeletal muscle and liver. In HIV+MS, we hypothesize that the elevated FFA Ra increases FFA delivery, uptake and oxidation by the myocardium, but that myocardial FFA uptake eventually exceeds the ability of the heart to oxidize FFAs: intramyocardial lipid accumulation may result. We hypothesize that increased myocardial FFA uptake and oxidation are associated with structural changes in the left ventricle, and ventricular diastolic and systolic contractile dysfunction in HIV+MS. We propose to quantify whole-body FFA Ra (using 13C-palmitate and mass spectrometry), myocardial FFA delivery, uptake and oxidation (using radio-labeled palmitate and cardiac positron emission tomography (PET) imaging), and left ventricular (LV) structure, diastolic and systolic contractile function using 2-D and tissue Doppler echocardiography) in 30 HIV+MS and 30 HIV-infected people without MS. We will compare these parameters between these 2 groups, and to exactly the same parameters quantified in HIV-seronegative people with and without "The Metabolic Syndrome" who are currently being studied by co-investigators on this proposal at our Institution. For this project, HIV+MS is defined as HIV-infected women and men receiving stable anti-retroviral therapy and experiencing hypertriglyceridemia, low HDL-cholesterol levels, insulin resistance and visceral adiposity. The findings will identify similarities/differences in myocardial metabolism and LV contractile function between HIV+MS and "The Metabolic Syndrome." The findings may provide a mechanistic link between dysregulated whole-body and myocardial FFA metabolism that contributes to alterations in LV structure, contractile function and CVD. If so, treatments designed to reduce circulating FFA levels in HIV+MS, might effectively reduce CVD and LVD in HIV-infected people.

这个子项目是众多研究子项目之一